Cargando…
Plasmodial Kinase Inhibitors: License to Cure?
[Image: see text] Advances in the genetics, function, and stage-specificity of Plasmodium kinases has driven robust efforts to identify targets for the design of antimalarial therapies. Reverse genomics following phenotypic screening against Plasmodia or related parasites has uncovered vulnerable ki...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical
Society
2018
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166223/ https://www.ncbi.nlm.nih.gov/pubmed/29771541 http://dx.doi.org/10.1021/acs.jmedchem.8b00329 |